This initiative unites Osaka Metropolitan University, K.K. DNAFORM, and the National Institute for Biomedical Research (INRB) in the Democratic Republic of the Congo. The collaboration centers on the GenPad platform, a portable isothermal nucleic acid amplification technology developed by DNAFORM. Because the system functions without large-scale laboratory equipment or stable power, it is specifically designed for high-stakes, resource-limited outbreak settings.

The investment covers prototype development and performance validation, moving toward clinical evaluation. The project aligns with the global 100-Day Mission, an initiative seeking to deploy medical countermeasures within 100 days of identifying a pandemic threat. Following the WHO's declaration of a Public Health Emergency of International Concern on May 16, 2026, the GHIT Fund accelerated its review process to fast-track this diagnostic solution, ensuring that isolation and contact tracing efforts in affected regions receive the necessary technical support.